(Reuters) -Emergent BioSolutions said on Wednesday it has appointed former Bausch + Lomb CEO Joseph Papa as head of the life sciences company, effective Feb. 21.
Shares of the company were up nearly 5% before the bell.
Papa has 35 years of experience in the healthcare industry and most recently served as CEO and Chairman at global eye health company Bausch + Lomb.
Shares of Emergent have fallen about 90% in the last 12 months, hitting a 16-year low in August, as the company struggled due to weakness in its contract research business.
(Reporting by Christy Santhosh; Editing by Krishna Chandra Eluri)
Comments